Medline Inc. Class A Common Stock (MDLN) — Capital Reinvestment Ratio
Medline Inc. Class A Common Stock (MDLN) has a Capital Reinvestment Ratio of 0.23x as of March 2026, meaning it reinvests 0% of its operating cash flow ($412.00 Million) in capital expenditures ($96.00 Million). See Medline Inc. Class A Common Stock (MDLN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medline Inc. Class A Common Stock Capital Reinvestment Ratio (2022–2025)
This chart tracks Medline Inc. Class A Common Stock's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Medline Inc. Class A Common Stock (2022–2025)
Year-by-year Capital Reinvestment Ratio for Medline Inc. Class A Common Stock from 2022 to 2025. For live market cap and broader valuation context, see market value of Medline Inc. Class A Common Stock.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | $1.74 Billion | $447.00 Million | ▲ +24.6% |
| 2024 | 0.21x | $1.77 Billion | $364.00 Million | ▲ +21.7% |
| 2023 | 0.17x | $1.69 Billion | $285.00 Million | ▼ -87.5% |
| 2022 | 1.36x | $187.00 Million | $254.00 Million | — |